Anthony D'Adamio - Mar 14, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & General Counsel
Signature
/s/Anthony D'Adamio
Stock symbol
BVS
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
4/12/2023, 09:03 PM
Previous filing
Feb 15, 2022
Next filing
Apr 5, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BVS Class A Common Stock 45.6K Mar 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Stock Option (Right to Buy) Award $0 +96.1K $0.00 96.1K Mar 14, 2022 Class A Common Stock 96.1K $12.66 Direct F1
transaction BVS Restricted Stock Units Award $0 +39.7K $0.00 39.7K Apr 10, 2023 Class A Common Stock 39.7K Direct F2, F3
transaction BVS Stock Option (Right to Buy) Award $0 +104K $0.00 104K Apr 10, 2023 Class A Common Stock 104K $1.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in four equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F3 The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.